Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified Bismuth Quadruple Therapy for H. Pylori Eradication
NCT07146594Phase 4Not yet recruiting
- Sponsor
- Athens Medical Center
- Start
- Aug 2025
- Primary completion
- May 2026
- Modality
- DNA Intercalators/Alkylators
01
Overview
A Phase 4 trial of esomeprazole, amoxicillin, metronidazole, bismuth subcitrate in Helicobacter pylori infection, sponsored by Athens Medical Center. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
esomeprazoleamoxicillinmetronidazolebismuth subcitrate
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT07146594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07146594.